{"id":"W3202620686","doi":"10.1016/j.annonc.2021.08.1883","title":"1281O Atezolizumab (atezo) vs platinum-based chemo in blood-based tumour mutational burden-positive (bTMB+) patients (pts) with first-line (1L) advanced/metastatic (m)NSCLC: Results of the Blood First Assay Screening Trial (BFAST) phase III cohort C","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":false,"ca_institutions":"William Osler Health System; University of Toronto","funders":"","keywords":"Atezolizumab; Medicine; Oncology; Internal medicine; Cancer; Immunotherapy; Nivolumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005294265,0.0004377909,0.0009454302,0.0001384529,0.0001402234,0.0006678842,0.000303856,0.0005394128,0.003411856],"category_scores_gemma":[0.0008630789,0.0001894481,0.000881741,0.0001697383,0.0002690987,0.0004821821,0.0001939522,0.001403348,0.0005142481],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005100012,"about_ca_system_score_gemma":0.0005041329,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001161897,"about_ca_topic_score_gemma":0.003834924,"domain_scores_codex":[0.9998277,0.00006784244,0.000008309737,0.00003490844,0.00001373549,0.00004747679],"domain_scores_gemma":[0.9996736,0.00009595436,0.00006642471,0.00002410017,0.00001356202,0.0001263459],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8503412,0.006464672,0.01266273,0.0003919847,0.000978583,0.00009144325,0.00008422315,0.001937088,0.01409264,0.0002378261,0.004827706,0.1078898],"study_design_scores_gemma":[0.4582826,0.414252,0.1066808,0.0001421694,0.002961651,0.0005459319,0.0001951502,0.00437303,0.004946182,0.0009363089,0.00662475,0.00005953114],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963241,0.001112995,0.0001001839,0.0003549568,0.0001287234,0.00007500913,0.0007561301,0.0000244609,0.001123445],"genre_scores_gemma":[0.9948769,0.0009113105,0.0001838994,0.0004182384,0.0001215368,0.00009466166,0.001311742,0.00001107154,0.002070569],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003411856,"threshold_uncertainty_score":0.01141381,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02076123226059324,"score_gpt":0.3031545853536468,"score_spread":0.2823933530930536,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}